These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30563304)

  • 1. Targeting microRNAs using nanotechnology in pulmonary diseases.
    Dua K; Chellappan DK; Singhvi G; de Jesus Andreoli Pinto T; Gupta G; Hansbro PM
    Panminerva Med; 2018 Dec; 60(4):230-231. PubMed ID: 30563304
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential of helper-dependent adenoviral vectors in modulating airway innate immunity.
    Kushwah R; Cao H; Hu J
    Cell Mol Immunol; 2007 Apr; 4(2):81-9. PubMed ID: 17484801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for pulmonary diseases.
    Kolb M; Martin G; Medina M; Ask K; Gauldie J
    Chest; 2006 Sep; 130(3):879-84. PubMed ID: 16963689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology in respiratory medicine.
    Omlor AJ; Nguyen J; Bals R; Dinh QT
    Respir Res; 2015 May; 16(1):64. PubMed ID: 26021823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in lung diseases: Recent findings and their pathophysiological implications.
    Ebrahimi A; Sadroddiny E
    Pulm Pharmacol Ther; 2015 Oct; 34():55-63. PubMed ID: 26319446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncovalent intracellular drug delivery of hydrophobic drugs on Au NPs.
    Doane T; Burda C
    Methods Mol Biol; 2013; 1025():251-60. PubMed ID: 23918343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging nanotechnology based strategies for diagnosis and therapeutics of urinary tract infections: A review.
    Kumar MS; Das AP
    Adv Colloid Interface Sci; 2017 Nov; 249():53-65. PubMed ID: 28668171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflections on microRNAs in chronic pulmonary disease: looking into the miR-ror and crystal ball.
    Karras JG; Sun G; Tay J; Jackson AL
    Inflamm Allergy Drug Targets; 2013 Apr; 12(2):88-98. PubMed ID: 23517647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term management of patients with end-stage lung diseases.
    Briganti DF; D'Ovidio F
    Best Pract Res Clin Anaesthesiol; 2017 Jun; 31(2):167-178. PubMed ID: 29110790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative care of chronic progressive lung disease.
    Bourke SJ; Peel ET
    Clin Med (Lond); 2014 Feb; 14(1):79-82. PubMed ID: 24532753
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of MicroRNAs in lung disease.
    Angulo M; Lecuona E; Sznajder JI
    Arch Bronconeumol; 2012 Sep; 48(9):325-30. PubMed ID: 22607962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology based therapeutics for lung disease.
    Doroudian M; MacLoughlin R; Poynton F; Prina-Mello A; Donnelly SC
    Thorax; 2019 Oct; 74(10):965-976. PubMed ID: 31285360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in pulmonary medicine (1).
    Weinberger SE
    N Engl J Med; 1993 May; 328(19):1389-97. PubMed ID: 8474515
    [No Abstract]   [Full Text] [Related]  

  • 14. Stabilizing gold nanoparticle bioconjugates in physiological conditions by PEGylation.
    Comenge J; Puntes VF
    Methods Mol Biol; 2013; 1025():281-9. PubMed ID: 23918346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory medicine team of the year.
    O'Dowd A
    BMJ; 2014 May; 348():g2941. PubMed ID: 24789473
    [No Abstract]   [Full Text] [Related]  

  • 16. MicroRNAs in Lung Development and Disease.
    Ameis D; Khoshgoo N; Iwasiow BM; Snarr P; Keijzer R
    Paediatr Respir Rev; 2017 Mar; 22():38-43. PubMed ID: 28237418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs in Lung Development and Diseases.
    Boateng E; Krauss-Etschmann S
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology-based therapeutics for targeting inflammatory lung diseases.
    Loo CY; Lee WH
    Nanomedicine (Lond); 2022 May; 17(12):865-879. PubMed ID: 35315290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Therapies in Outpatient Pulmonary Medicine.
    Granados L; John M; Edelman JD
    Med Clin North Am; 2024 Sep; 108(5):843-869. PubMed ID: 39084837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric control of nanomechanical DNA origami pinching devices for enhanced target binding.
    Kuzuya A; Sakai Y; Yamazaki T; Xu Y; Yamanaka Y; Ohya Y; Komiyama M
    Chem Commun (Camb); 2017 Jul; 53(59):8276-8279. PubMed ID: 28681899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.